PS PeptideSuppliers.org Finding the right peptide supplier for you
MOTS-c reference image
View supplier listing 15% off with code PPL15
Peptide guide

MOTS-c Peptide Guide & Supplier Listing Notes

Mitochondrial-derived peptide

Mitochondrial-derived peptide research

Longevity and cellular research compounds Educational guide Supplier transparency
Back to directory Compare supplier pages
Educational disclaimer

Informational reference only

This page is for educational and informational purposes only. PeptideSuppliers.org does not sell peptides, provide medical advice, or recommend human use.

Overview

MOTS-c overview

MOTS-c is a mitochondrial-derived peptide. Published research most often places it within metabolism, insulin sensitivity, exercise physiology, and aging biology.

The literature around MOTS-c is usually interpreted through mechanism, study design, and compound identity. Closely related analogs, shorthand labels, and supplier naming conventions can make those distinctions especially important when comparing papers, trial records, and catalog listings.

Emerging research compound; not approved therapeutic. This broader context helps separate established findings from early-stage signals and keeps the compound anchored to the evidence base rather than to marketing language.

Research snapshot

Quick research reference

Research Category: Cellular Longevity Research

Research Status: Emerging research compound; not approved therapeutic.

Common Areas Studied:

  • Metabolism, insulin sensitivity, exercise physiology, aging biology

Related Compounds:

History

Where the compound came from and why researchers keep returning to it.

The history of MOTS-c is easiest to understand as part of a broader research line rather than as a single isolated listing. Discovered within mitochondrial DNA-encoded small open reading frames; part of mitochondrial-derived peptide field.

That history is important because it shows what problem researchers were trying to solve, what earlier compounds shaped the field before MOTS-c gained attention, and why the compound continues to be discussed in relation to later studies or newer analogs.

MOTS-c's research history is comparatively recent: it was identified in 2015 as a peptide encoded within mitochondrial DNA rather than nuclear DNA, which places it in a different discovery category than most peptides on this site that were designed or derived from known hormone sequences.

Mechanism of Action

Receptors, pathways, and the biological logic that shapes the research conversation.

MOTS-c is proposed to act through AMPK and metabolic signaling, cellular stress response, glucose metabolism, and mitochondrial communication, though the underlying mechanisms remain under study. This is the core biological reason MOTS-c is discussed alongside compounds such as humanin, other mitochondrial-derived peptides (SHLPs), epitalon, and NAD+.

For MOTS-c, that means tracking how its proposed activity on AMPK signaling and metabolic regulation is distinct from the mitochondrial biogenesis pathways studied for other 'mitochondrial peptide' compounds, since MOTS-c's mechanism centers on nuclear-mitochondrial communication rather than direct organelle repair.

MOTS-c is sometimes grouped loosely with other 'longevity peptides' like Epitalon or NAD+ precursors despite having a distinct, mitochondrially-encoded origin and a different proposed mechanism: AMPK-linked metabolic signaling rather than telomerase or redox pathways.

Early MOTS-c research focused on basic characterization of the peptide's mitochondrial origin and metabolic effects in cell models; more recent work has moved toward exercise-physiology and insulin-sensitivity endpoints in animal models, which is where current research interest is concentrated.

Research Areas

The main research domains where this compound appears most often.

Research area

Metabolic regulation

Metabolic studies often look at lipids, insulin sensitivity, liver markers, inflammatory signals, or composite risk patterns that sit outside a single disease label.

Research area

Exercise adaptation

Published work in this area varies by model, endpoint, and stage of development, so the most useful reading approach is to focus on the specific outcomes each study actually measures.

Research area

Insulin sensitivity

Published work in this area varies by model, endpoint, and stage of development, so the most useful reading approach is to focus on the specific outcomes each study actually measures.

Research area

aging biology

These studies usually examine cellular stress, senescence pathways, telomere-related biology, mitochondrial function, or other markers used in aging research.

Research area

Mitochondrial stress response

Neurobiology papers in this area often focus on signaling pathways, behavioral models, neuroprotection hypotheses, or stress-response markers tied to the compound.

Animal studies

What preclinical work has emphasized

Preclinical studies have examined metabolic and aging-related endpoints in animal and cell models. This part of the literature often sets the first expectations around mechanism, tissue effects, or metabolic signaling, but those early signals need to be read with the normal limits of preclinical work in mind.

MOTS-c preclinical work relies heavily on rodent exercise and metabolic-challenge models, with administration routes and dosing schedules that are specific to those experimental designs rather than to any established human dosing pattern.

The clearest MOTS-c summaries specify whether a study measured insulin sensitivity, exercise capacity, or cellular AMPK activation directly, since these represent different levels of evidence for what remains a fairly young research literature.

Human studies

How much human evidence exists

Human research on MOTS-c remains early and limited compared with established drugs. When human data do exist, the best summaries distinguish the type of study being discussed, the population under investigation, and the limits of what the results can show.

MOTS-c has very limited published human data compared to older, more established peptides, and most of what does exist comes from small pilot-scale studies rather than the larger trial programs seen for compounds like GLP-1 analogs.

Given how recently MOTS-c was identified, its human-study record is thin, and readers should weigh that recency against any claims that treat the compound as having an established safety or efficacy profile.

Current research status

Where the research stands now

Emerging research compound; not approved therapeutic. For MOTS-c, the current research picture should be read as a snapshot rather than a final verdict, because publication timelines, trial readouts, and category language can shift quickly.

MOTS-c's online visibility in longevity and fitness communities has grown quickly, but the underlying trial record remains mostly preclinical; this is one of the wider gaps between marketing presence and published human evidence among compounds on this site.

PubMed searches for MOTS-c alongside 'mitochondrial-derived peptide' surface the foundational discovery literature, which is useful context before reading more recent metabolic-research papers that assume familiarity with the compound's origin.

Browse suppliers Open peptide directory Read education guides Best peptide suppliers

Related Compounds

Closely related compounds frequently discussed within the same research category.

Epitalon NAD+
Supplier considerations

How to read supplier pages more carefully

Require identity, purity, careful storage, batch COA, no anti-aging treatment claims. In this context, the main issue is documentation quality rather than promotional language.

For MOTS-c, documentation quality starts with naming discipline. If a listing uses shorthand, category labels, or adjacent compound references, the exact compound identity should still be easy to follow. COAs, third-party testing notes, and batch references should reinforce that naming rather than complicate it.

MOTS-c is typically supplied as a lyophilized peptide requiring refrigerated storage before reconstitution, consistent with handling requirements for other small research peptides covered on this site.

  • Look for batch-specific COAs instead of generic laboratory files reused across many listings.
  • Check whether the product name, concentration language, and batch references stay consistent from page to page.
  • Read storage and handling notes alongside the document links rather than treating the headline purity claim as enough.
  • Prefer supplier pages that keep research-use labeling, contact details, and policy pages easy to verify.

Linked supplier pages

Supplier pages that help compare naming, documentation access, batch references, and overall page clarity.

Supplier listing

Pinnacle Peptide Labs

This listing helps with checking naming, documentation access, storage language, and overall page clarity.

View supplier listing
15% off with code PPL15

Frequently Asked Questions

Common research questions about the compound, evidence base, and supplier documentation.

What is MOTS-c?

MOTS-c is a mitochondrial-derived peptide. Research literature on this compound is usually interpreted through mechanism, evidence level, and documentation quality.

Is it mitochondrial?

Yes. MOTS-c is encoded within mitochondrial DNA, which is why it is classified as a mitochondrial-derived peptide alongside compounds like humanin.

What does it do in research?

MOTS-c is proposed to act through AMPK and metabolic signaling, cellular stress response, glucose metabolism, and mitochondrial communication, though the mechanisms remain under study. That pathway-level description captures the main biological rationale being studied.

Human evidence?

Human research is early/limited compared with established drugs. The study type and its limitations matter, because small exploratory reports and larger controlled trials do not carry the same weight.

What is a mitochondrial-derived peptide?

MOTS-c is a mitochondrial-derived peptide. Research literature on this compound is usually interpreted through mechanism, evidence level, and documentation quality.

Why studied in metabolism?

MOTS-c is studied in metabolism because of its proposed role in AMPK signaling and glucose regulation, which researchers link to exercise adaptation and insulin sensitivity in preclinical models.

What research areas is MOTS-c usually linked to?

The main areas linked to MOTS-c in this literature are metabolic regulation, exercise adaptation, insulin sensitivity, aging biology, and mitochondrial stress response. Those categories reflect the published research record around the compound.

What should be verified on a MOTS-c supplier page?

Require identity, purity, careful storage, batch COA, no anti-aging treatment claims. In practice, that means checking batch-specific COAs, identity/purity language, research-use labeling, and overall page consistency.

How developed is the current MOTS-c research literature?

Emerging research compound; not approved therapeutic. Trial records and literature searches are still the best way to verify where the field stands at any given point.

What makes MOTS-c different from related compounds?

MOTS-c is most usefully compared through mechanism and category fit. Nearby entries such as Epitalon, NAD+ help show how receptor logic, research emphasis, and documentation patterns differ without treating all of them as interchangeable.

References

Research entry points and source pages for verifying the broader literature.